Victory Capital Management
PRAH

Victory Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Victory Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,168
Closed -$1.35M – 2901
2021
Q2 		$1.35M Sell
8,168
-7,866
-49% -$1.31M ﹤0.01% 1776
2021
Q1 		$2.46M Sell
16,034
-22,658
-59% -$3.08M ﹤0.01% 1588
2020
Q4 		$4.85M Sell
38,692
-4,871
-11% -$545K 0.01% 1248
2020
Q3 		$4.42M Buy
43,563
+2,356
+6% +$240K 0.01% 1224
2020
Q2 		$4.01M Sell
41,207
-35,863
-47% -$3.34M 0.01% 1214
2020
Q1 		$6.4M Buy
77,070
+30,693
+66% +$2.99M 0.01% 1203
2019
Q4 		$5.16M Buy
46,377
+2,076
+5% +$214K 0.01% 1180
2019
Q3 		$4.4M Buy
44,301
+21,016
+90% +$2.09M 0.01% 1196
2019
Q2 		$2.31M Buy
23,285
+264
+1% +$25.2K ﹤0.01% 1104
2019
Q1 		$2.54M Buy
+23,021
New +$2.41M 0.01% 1036
2016
Q3 		– Sell
-1,369
Closed -$57K – 1858
2016
Q2 		$57K Buy
1,369
+597
+77% +$27.5K ﹤0.01% 1486
2016
Q1 		$33K Buy
+772
New +$32.6K ﹤0.01% 1545

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Victory Capital Management's PRAH Position: Q3 2021 in Review

Victory Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 8,168 shares — an estimated $1.35M sold.

Victory Capital Management first reported a position in PRAH in Q1 2016 and held it in 12 quarters. The position peaked at $6.4M in Q1 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Victory Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Victory Capital Management sold 8,168 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.35M.
  • Victory Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 12 quarters.
  • Victory Capital Management's PRA Health Sciences, Inc. position peaked at $6.4M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.